June 10, 2009
New Capabilities Will Further Extend GeneXpert System Technology Advantages SUNNYVALE, Calif., June 10 -- Cepheid (Nasdaq: CPHD - News) today announced that it has received a notice of grant award from the National Institute of Allergy and Infectious Diseases to develop new ten-color detection technology for use in its GeneXpert® System. The $7.5 million grant [...]
Thermo Fisher Scientific Unveils a New Solution to Increase Sensitivity of In Vitro Toxicity Testing
June 9, 2009
The Thermo Scientific Cellomics ToxInsight IVT Platform Boston, MA., (June 9, 2009) - Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Thermo Scientific Cellomics ToxInsight Solution at the World Pharmaceutical Congress, June 9-11 2009, Philadelphia. The Thermo Scientific Cellomics ToxInsight Solution offers a unique combination of imaging [...]
June 9, 2009
International Sales Veteran to Lead Certara’s Emerging Translational Pharmacology Business Group in Europe ST. LOUIS, Mo.--Certara™, a global, emerging translational pharmacology company, formed by the acquisition of Pharsight® Corporation by Tripos™, today announced the appointment of William Cobert to lead its European sales group. Mr. Cobert will manage a combined sales team for Tripos and [...]
Sigma-Aldrich Introduces New Services Network Complementing Its Life Sciences Product Portfolio
June 9, 2009
Customers can now conveniently access a collection of support services that can be used on a short or long term basis to accelerate their research ST. LOUIS, June 9 -- Sigma-Aldrich (Nasdaq: SIAL - News) today announced the launch of its new Services Network designed to provide laboratory services for the pharmaceutical and biotechnology industry. [...]
June 9, 2009
Clarus Ventures Leads Financing SEATTLE--NanoString Technologies, a privately held life sciences company advancing best-in-class technologies for expression profiling, announced today that it has closed a $30 million Series C equity financing. This financing, structured in two tranches, will allow NanoString Technologies to accelerate the commercialization of the nCounter™ Analysis System in the research tools and [...]
Luminex Launches Two New Cystic Fibrosis Tests in Europe
June 9, 2009
CE IVD Marked Tests Can Quickly and Accurately Detect Up to 39 and 71 Cystic Fibrosis Gene Mutations AUSTIN, Texas--Luminex Corporation (NASDAQ: LMNX - News), the worldwide leader in multiplexed solutions, today announced that it has launched two new cystic fibrosis (CF) tests in Europe, the xTAG® Cystic Fibrosis 39 Kit v2 and xTAG® Cystic [...]
CSIRO deal to commercialise ‘artificial gut’
June 9, 2009
CSIRO Food Futures National Research Flagship and Australian company Stadvis Pty Ltd have signed a worldwide license agreement to commercialise an automated instrument that accurately predicts glycemic index (GI) and resistant starch (RS) in food products. 9 June 2009 The machine will provide the food industry with an accurate means of testing the functional properties [...]
Fast Pandemic Detection Tool Ready to Fight Flu
June 9, 2009
Agilent Technologies and Los Alamos Develop First High-Throughput System to Be Deployed at UCLA’s New Global Bio Lab SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A) today announced researchers are developing new tools for rapidly characterizing biological pathogens that could give rise to potentially deadly pandemics such as Influenza A (H1N1). This is part of a joint [...]
June 9, 2009
MUNICH and MEXICO CITY--The Advalytix product team of Olympus, Implen, and AmpliBio jointly announce that the Mexican Ministry of Agriculture (SAGARPA) awarded AmpliBio a contract for 17 GENE LABs – AmpliBio’s turnkey solution for molecular analysis. Each GENE LAB will contain Advalytix’s AmpliSpeed single cell molecular analysis cycler, and Implen’s Nanophotometer to quantify DNA, RNA [...]
Commonwealth Biotechnologies, Inc. Announces Agreement to Acquire GL Biochem (Shanghai) Ltd
June 8, 2009
Transformative Transaction to Create the Global Market Leader in the Development and Supply of Research-Grade Custom Peptides RICHMOND, Va.--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) is pleased to announce that it has executed an agreement to acquire all of the outstanding shares of GL Biochem (Shanghai) Ltd (“GL Biochem”), a privately owned Shanghai-based chemical company [...]